Skip to main content

and
  1. Article

    Open Access

    A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia

    T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological cancer for which treatment options often result in incomplete therapeutic efficacy and long-term side-effects. Interleukin 7 (IL-7) an...

    Padma Akkapeddi, Rita Fragoso, Julie A. Hixon, Ana Sofia Ramalho in Leukemia (2019)